246
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Association Between Cognitive Functions and Psychological Factors in Patients with Severe COPD

ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 2065-2078 | Received 20 Jun 2023, Accepted 06 Sep 2023, Published online: 19 Sep 2023

References

  • Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–922. doi:10.1183/09031936.00125109
  • Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S49621
  • Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822–832. doi:10.1183/09031936.06.00145104
  • Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–1519. doi:10.1161/01.CIR.0000056767.69054.B3
  • Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(12):1286–1293. doi:10.1164/rccm.200406-754OC
  • Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60(7):570–575. doi:10.1136/thx.2004.037135
  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. doi:10.1183/09031936.00012408
  • Villeneuve S, Pepin V, Rahayel S, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142(6):1516–1523. doi:10.1378/chest.11-3035
  • Wang Y, Li B, Li P, et al. Severe obstructive sleep apnea in patients with chronic obstructive pulmonary disease is associated with an increased prevalence of mild cognitive impairment. Sleep Med. 2020;75:522–530. doi:10.1016/j.sleep.2020.05.002
  • Schou L, Østergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease--a systematic review. Respir Med. 2012;106(8):1071–1081. doi:10.1016/j.rmed.2012.03.013
  • Torres-Sánchez I, Rodríguez-Alzueta E, Cabrera-Martos I, López-Torres I, Moreno-Ramírez MP, Valenza MC. Cognitive impairment in COPD: a systematic review. J Bras Pneumol. 2015;41(2):182–190. doi:10.1590/S1806-37132015000004424
  • Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest. 2012;141(6):1601–1610. doi:10.1378/chest.11-2214
  • Tudorache E, Fildan AP, Frandes M, Dantes E, Tofolean DE. Aging and extrapulmonary effects of chronic obstructive pulmonary disease. Clin Interv Aging. 2017;12:1281–1287. doi:10.2147/CIA.S145002
  • Thakur N, Blanc PD, Julian L, et al. COPD and cognitive impairment: the role of hypoxemia and oxygen therapy. Am J Respir Critical Care Med Conference. 2010;181(1):263.
  • Martini A, Castiglione A, Bovo R, Vallesi A, Gabelli C. Aging, cognitive load, dementia and hearing loss. Audiol Neurootol. 2014;19 Suppl 1:2–5. doi:10.1159/000371593
  • Humes LE, Young LA. Sensory-Cognitive Interactions in Older Adults. Ear Hear. 2016;37 Suppl 1(Suppl 1):52s–61s. doi:10.1097/AUD.0000000000000303
  • Antonelli-Incalzi R, Corsonello A, Trojano L, et al. Correlation between cognitive impairment and dependence in hypoxemic COPD. J Clin Exp Neuropsychol. 2008;30(2):141–150. doi:10.1080/13803390701287390
  • Incalzi RA, Gemma A, Marra C, Capparella O, Fuso L, Carbonin P. Verbal memory impairment in COPD: its mechanisms and clinical relevance. Chest. 1997;112(6):1506–1513. doi:10.1378/chest.112.6.1506
  • Suh HS, Chang MS, Yu I, et al. Adherence to Long-Acting Inhaler Use for Initial Treatment and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a Retrospective Cohort Study. J Pers Med. 2022;12(12):2073. doi:10.3390/jpm12122073
  • Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142(8):1470–1476. doi:10.1001/archinte.1982.00340210062015
  • Antonelli-Incalzi R, Corsonello A, Pedone C, et al. Drawing impairment predicts mortality in severe COPD. Chest. 2006;130(6):1687–1694. doi:10.1378/chest.130.6.1687
  • Crişan AF, Oancea C, Timar B, Fira-Mladinescu O, Crişan A, Tudorache V. Cognitive impairment in chronic obstructive pulmonary disease. PLoS One. 2014;9(7):e102468. doi:10.1371/journal.pone.0102468
  • Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med. 2004;98(4):351–356. doi:10.1016/j.rmed.2003.11.004
  • von Siemens SM, Perneczky R, Vogelmeier CF, et al. The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort. Respir Res. 2019;20(1):257. doi:10.1186/s12931-019-1217-5
  • Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–1440. doi:10.1378/chest.121.5.1434
  • Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–1774. doi:10.1016/j.rmed.2006.01.026
  • Schane RE, Walter LC, Dinno A, Covinsky KE, Woodruff PG. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med. 2008;23(11):1757–1762. doi:10.1007/s11606-008-0749-z
  • Mendelsohn C. Smoking and depression--a review. Aust Fam Physician. 2012;41(5):304–307.
  • Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–e671. doi:10.1016/S2468-2667(20)30185-7
  • Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • Yin M, Wang H, Hu X, Li X, Fei G, Yu Y. Patterns of brain structural alteration in COPD with different levels of pulmonary function impairment and its association with cognitive deficits. BMC Pulm Med. 2019;19(1):203. doi:10.1186/s12890-019-0955-y
  • Beratis IN, Andronas N, Kontaxopoulou D, et al. Driving in mild cognitive impairment: the role of depressive symptoms. Traffic Inj Prev. 2017;18(5):470–476. doi:10.1080/15389588.2016.1265648
  • George CF, Boudreau AC, Smiley A. Effects of nasal CPAP on simulated driving performance in patients with obstructive sleep apnoea. Thorax. 1997;52(7):648–653. doi:10.1136/thx.52.7.648
  • Prior TS, Troelsen T, Hilberg O. Driving performance in patients with chronic obstructive lung disease, interstitial lung disease and healthy controls: a crossover intervention study. BMJ Open Respiratory Research. 2015;2(1):1–6.
  • Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
  • Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
  • United Nations Educational, Scientific and Cultural Organization. International Standard Classification of Education ISCED 2011. United Nations Educational, Scientific and Cultural Organization (UNESCO); 2011.
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–545. doi:10.1093/sleep/14.6.540
  • Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
  • Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77. doi:10.1016/S0022-3999(01)00296-3
  • Eskildsen A, Dalgaard VL, Nielsen KJ, et al. Cross-cultural adaptation and validation of the Danish consensus version of the 10-item Perceived Stress Scale. Scand J Work Environ Health. 2015;41(5):486–490. doi:10.5271/sjweh.3510
  • Cairns A, Wickwire E, Schaefer E, Nyanjom D. A pilot validation study for the NOX T3(TM) portable monitor for the detection of OSA. Sleep Breath. 2014;18(3):609–614. doi:10.1007/s11325-013-0924-2
  • Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
  • Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kędziora-Kornatowska K. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016;50(5):1039–1052. doi:10.12740/PP/45368
  • Land M, Horwood J. Which parts of the road guide steering? Nature. 1995;377(6547):339–340. doi:10.1038/377339a0
  • Lauridsen MM, Thiele M, Kimer N, Vilstrup H. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis. 2013;28(2):231–234. doi:10.1007/s11011-012-9373-z
  • Wong GKC, Mak JSY, Wong A, et al. Minimum Clinically Important Difference of Montreal Cognitive Assessment in aneurysmal subarachnoid hemorrhage patients. J Clin Neurosci. 2017;46:41–44. doi:10.1016/j.jocn.2017.08.039
  • Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5):858–866. doi:10.4187/respcare.01862
  • Dulohery MM, Schroeder DR, Benzo RP. Cognitive function and living situation in COPD: is there a relationship with self-management and quality of life? Int J Chron Obstruct Pulmon Dis. 2015;10:1883–1889. doi:10.2147/COPD.S88035
  • Yohannes AM, Eakin M, Holbrook JT, et al. Association of mild cognitive impairment and characteristic of COPD and overall health status in a cohort study. Expert Rev Respir Med. 2021;15(1):153–159. doi:10.1080/17476348.2021.1838278
  • Pierobon A, Bottelli ES, Ranzini L, et al. COPD patients’ self-reported adherence, psychosocial factors and mild cognitive impairment in pulmonary rehabilitation. International Journal of COPD. 2017;12:2059–2067. doi:10.2147/COPD.S133586
  • Ozturk HM, Ogan N, Erdogan M, Akpinar EE, Ilgar C, Ozturk S. The association between total cholesterol and cognitive impairment in chronic obstructive pulmonary disease patients. Prostaglandins Other Lipid Mediat. 2023;164:106697. doi:10.1016/j.prostaglandins.2022.106697
  • Andrianopoulos V, Gloeckl R, Scheeberger T, et al. Changes in cognitive function of cognitively impaired patients with COPD after pulmonary rehabilitation and 1-year follow-up. Eur Respir J Conference. 2018;52(62):PA3649.
  • Lv Z, Hu P, Jiang Y, et al. Changes in Spatial Working Memory in Stable Chronic Obstructive Pulmonary Disease: a Retrospective Study. Biomed Res Int. 2020;2020:7363712. doi:10.1155/2020/7363712
  • Farver-Vestergaard I, Rubio-Rask S, Timm S, Christiansen CF, Hilberg O, Løkke A. Disease-Specific Anxiety in Chronic Obstructive Pulmonary Disease: translation and Initial Validation of a Questionnaire. Front Psychol. 2022;13:907939. doi:10.3389/fpsyg.2022.907939
  • Kühl K, Kuhn C, Kenn K, Rief W. The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients. Psychother Psychosom Med Psychol. 2011;61(1):e1–9. doi:10.1055/s-0030-1248281
  • Phibbs S, Stawski RS, MacDonald SWS, Munoz E, Smyth JM, Sliwinski MJ. The influence of social support and perceived stress on response time inconsistency. Aging Ment Health. 2019;23(2):214–221. doi:10.1080/13607863.2017.1399339
  • MacDonald SW, Nyberg L, Bäckman L. Intra-individual variability in behavior: links to brain structure, neurotransmission and neuronal activity. Trends Neurosci. 2006;29(8):474–480. doi:10.1016/j.tins.2006.06.011
  • Au B, Dale-McGrath S, Tierney MC. Sex differences in the prevalence and incidence of mild cognitive impairment: a meta-analysis. Ageing Res Rev. 2017;35:176–199. doi:10.1016/j.arr.2016.09.005